Mycobacterium leprae is one of those Step 1 bugs that feels deceptively “simple” (skin + nerves), but the test writers love it because it connects microbiology, immunology (Th1 vs Th2), pathology (granulomas vs foamy macrophages), and pharm (multidrug therapy + adverse effects). If you can explain why two patients infected with the same organism can look completely different clinically, you basically own leprosy questions.
What is Mycobacterium leprae?
Core definition: M. leprae is an acid-fast, obligate intracellular mycobacterium that preferentially infects Schwann cells (peripheral nerves) and skin macrophages, causing leprosy (Hansen disease).
High-yield organism facts (Step 1 favorites)
- Acid-fast bacillus due to mycolic acids in cell wall
- First Aid tie-in: Acid-fast organisms section (Mycobacteria; acid-fast staining)
- Obligate intracellular; grows best in cooler body regions (skin, peripheral nerves, nasal mucosa)
- Cannot be cultured on standard artificial media
- Has a very long doubling time and long incubation period (often years)
- Reservoir & transmission: humans; classically associated with armadillos in the southern US
- Transmission is thought to occur via respiratory droplets with prolonged close contact
Pathophysiology: why skin + nerves?
Tropism for Schwann cells → neuropathy
M. leprae binds and invades Schwann cells, leading to:
- Demyelination and nerve damage
- Loss of pain/temperature sensation → repeated trauma, burns, secondary infections
- Muscle weakness and atrophy (later)
Immune response determines the clinical form (the “big idea”)
On exams, leprosy isn’t just one disease—it's a spectrum determined by the host T-cell response:
| Feature | Tuberculoid leprosy | Lepromatous leprosy |
|---|---|---|
| Dominant immune response | Th1 (strong cell-mediated immunity) | Th2 (weak cell-mediated immunity) |
| Cytokines | IFN-γ, IL-2 | IL-4, IL-10 |
| Bacterial burden | Low (paucibacillary) | High (multibacillary) |
| Lesions | Few, well-demarcated | Numerous, symmetric, diffuse |
| Sensation | Markedly decreased in lesions | More widespread neuropathy |
| Histology | Granulomas | Foamy macrophages |
| Acid-fast stain | Often negative/scant organisms | Lots of AFB (“packed”) |
| Lepromin skin test | Positive | Negative |
First Aid cross-reference: This is the same immunology logic used for other intracellular pathogens—Th1 = macrophage activation = granulomas.
Clinical presentation: what does it look like?
Shared features across the spectrum
- Hypopigmented or erythematous skin lesions
- Peripheral neuropathy: numbness, paresthesias, loss of pain/temperature
- Thickened peripheral nerves (classically ulnar, peroneal, posterior tibial)
- Chronic course with long incubation
Tuberculoid leprosy (Th1 “containment”)
Think: few lesions, well-defined, anesthetic patches.
- One or a few hypopigmented plaques with raised borders
- Prominent sensory loss over lesions early
- Asymmetric nerve involvement
- Granulomatous inflammation → fewer organisms
Classic vignette clue: A patient with a single hypopigmented patch that is numb to pinprick.
Lepromatous leprosy (Th2 “dissemination”)
Think: diffuse, symmetric, loads of organisms.
- Numerous lesions: macules, papules, nodules, plaques
- Symmetric skin involvement; more extensive disease
- Diffuse facial infiltration → leonine facies
- Nasal mucosa involvement → chronic congestion, epistaxis, possible septal damage
- Testicular involvement → infertility (can show up as systemic clue)
- “Foamy” macrophages stuffed with bacilli
Classic vignette clue: Diffuse nodular skin lesions + leonine facies + negative lepromin test.
Diagnosis: how Step questions expect you to confirm it
Clinical suspicion (most important)
- Skin lesions + sensory loss is the big red flag.
- Evaluate peripheral nerve function (pain/temp sensation) and palpate for nerve thickening.
Laboratory confirmation
- Acid-fast staining of skin lesions or nasal secretions
- More sensitive in lepromatous disease (high organism burden)
- Skin biopsy:
- Tuberculoid: granulomas, few organisms
- Lepromatous: foamy macrophages with numerous AFB
The lepromin skin test (Step 1 immunology favorite)
- Not the same as TB PPD; it’s used to classify leprosy.
- Positive = tuberculoid (intact cell-mediated immunity)
- Negative = lepromatous (poor cell-mediated immunity)
First Aid cross-reference: Often listed alongside leprosy spectrum and Th1/Th2 patterns.
Treatment: what to memorize (and what the exam will ask)
Core principle: multidrug therapy (prevent resistance)
Standard regimens depend on disease classification, but Step-level takeaways:
- Dapsone + rifampin for tuberculoid (paucibacillary)
- Dapsone + rifampin + clofazimine for lepromatous (multibacillary)
Drug pearls (high yield)
- Dapsone
- MOA: inhibits dihydropteroate synthase (folate synthesis)
- Adverse effects: hemolysis in G6PD deficiency, methemoglobinemia, hypersensitivity
- Rifampin
- MOA: inhibits DNA-dependent RNA polymerase
- Adverse effects: orange body fluids, CYP450 induction, hepatotoxicity
- Clofazimine
- High-yield adverse effect: skin discoloration (reddish-brown/black) and GI effects
First Aid cross-reference: Leprosy treatment is typically listed with “dapsone + rifampin ± clofazimine” and the classic toxicity tie-ins (especially G6PD hemolysis for dapsone).
High-yield associations & classic USMLE traps
1) “Acid-fast + peripheral neuropathy + skin lesions”
When you see hypopigmented anesthetic patches, think M. leprae first.
2) Spectrum = immunology question in disguise
They may not even ask “which organism”—they’ll ask:
- Which T-helper response predominates?
- Which cytokines?
- What would the lepromin test show?
Quick map:
- Tuberculoid → Th1, granulomas, positive lepromin
- Lepromatous → Th2, foamy macrophages, negative lepromin
3) “Cooler areas” clue
Lesions often involve:
- Earlobes, nose, fingers/toes
This is a subtle reason the organism thrives there.
4) Armadillos
A Step-friendly epidemiology clue, especially in US vignettes (Texas/Louisiana/Florida themes).
5) Nerve damage → secondary injuries
The morbidity comes less from the bacteria and more from loss of protective sensation, leading to:
- Ulcers
- Osteomyelitis
- Deformities (late)
Rapid review (what to recall in 20 seconds)
- Organism: Mycobacterium leprae = acid-fast, intracellular, Schwann cell tropism, can’t be cultured easily
- Key clinical: skin lesions + sensory loss
- Spectrum:
- Tuberculoid: Th1, granulomas, few lesions, paucibacillary, lepromin+
- Lepromatous: Th2, foamy macrophages, diffuse lesions, multibacillary, lepromin−, leonine facies
- Tx: dapsone + rifampin ± clofazimine (watch G6PD hemolysis with dapsone)